相关实验视频

Updated: Jul 9, 2025

Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes

Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes

Published on: December 16, 2022

对于CRISPR-Cas9交付的外基因组:基因组编辑的尖端

Cynthia Aslan¹, Naime Majidi Zolbanin^2,3, Fatemeh Faraji⁴

¹Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Molecular biotechnology

|November 27, 2023

概括

聚类正规间隔短平行体重复 (CRISPR) 基因编辑提供了新的治疗潜力. 外基因组在临床应用中显示出作为CRISPR/Cas9技术生物相容的传递系统的前景.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
遗传学是一个遗传学.

背景情况:

基因编辑技术随着CRISPR-Cas9.9的出现而取得了显著的进步.
克里斯普尔-Cas9超越了早期基因编辑工具 (如指核酶和TALENs) 的局限性.
治疗性基因编辑对各种疾病具有前景,包括心血管,神经和遗传性疾病.

研究的目的:

审查CRISPR/Cas9介导基因组修饰的分子机制和挑战.
讨论CRISPR/Cas9在疾病治疗和诊断中的应用.
突出了基于外体的传递系统在CRISPR/Cas9.9的进步.

主要方法:

审查关于CRISPR/Cas9技术的当前科学文献.
对CRISPR/Cas9基因编辑背后的分子机制的分析.
对药物输送应用的外体特征的评估.

主要成果:

克里斯普尔-Cas9是一种强大的基因组修改工具,可以进行治疗干预.
对CRISPR/Cas9系统的有效交付仍然是一个重大挑战.
外基因组为CRISPR/Cas9传递提供了一个有希望的,生物相容和低免疫性解决方案.

结论:

克里斯普尔/卡斯9技术正在彻底改变基因组修饰和治疗策略.
外体介导的传递提供了一种可行的方法来克服当前的CRISPR/Cas9传递挑战.
对于未来的CRISPR/Cas9疗法的临床转化,外体细胞递送系统的进一步开发至关重要.

关键词:

这就是CRISPR/Cas9的作用.外基因组是外基因组的组成部分.基因治疗是一种基因疗法.

更多相关视频

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...